Paragon Biomedical (Now Clinipace Worldwide)
ResearchNorth Carolina, United States201-500 Employees
Clinipace Worldwide provides contract research services that support the development of drugs and medical devices, covering regulatory strategy, clinical development, and post-approval research. The work is enabled by TEMPO, the company's proprietary eClinical platform. Clinipace traces its origins to the 2012 acquisition of Paragon Biomedical, a firm based in Morrisville, North Carolina, and the combined organization is headquartered in Research Triangle Park, North Carolina, with regional offices across North America, Europe, the Middle East and Asia, and South America. Positioned as a digital CRO, Clinipace has managed a broad portfolio of global clinical research, regulatory, and quality assurance projects. It has been recognized by Forbes in 2012 as one of America's Most Promising Companies and appeared on Inc. Magazine's Inc. 500 list for three consecutive years. In 2021, the company announced a merger with Shanghai-based dMed Global and named Simon Britton as Chief Operating Officer, signaling ongoing expansion.
1-888-653-2347 
support@leadiq.com 
